BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1884 related articles for article (PubMed ID: 29167021)

  • 21. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
    Ivanova VS; Davies J; Menter T; Wild D; Müller A; Krasniqi F; Stenner F; Papachristofilou A; Dirnhofer S; Tzankov A
    Histopathology; 2024 Feb; 84(3):525-538. PubMed ID: 37965677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of heterogeneity of extranodal and nodal diffuse large B cell lymphoma].
    Yin HF; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):158-62. PubMed ID: 17440591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma.
    Hill BT; Sweetenham J
    Leuk Lymphoma; 2012 May; 53(5):763-9. PubMed ID: 21992676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical subtyping of diffuse large B-cell lymphoma into germinal center B-cell and activated B-cell subtype, along with correlation of the subtypes with extranodal involvement, serum lactate dehydrogenase, and positron emission tomography scan-based response assessment to chemotherapy.
    Tyagi A; Abrari A; Khurana A; Tyagi S
    J Cancer Res Ther; 2022; 18(4):1129-1136. PubMed ID: 36149172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
    Ruminy P; Etancelin P; Couronné L; Parmentier F; Rainville V; Mareschal S; Bohers E; Burgot C; Cornic M; Bertrand P; Lenormand B; Picquenot JM; Jardin F; Tilly H; Bastard C
    Leukemia; 2011 Apr; 25(4):681-8. PubMed ID: 21233831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
    Iqbal J; Greiner TC; Patel K; Dave BJ; Smith L; Ji J; Wright G; Sanger WG; Pickering DL; Jain S; Horsman DE; Shen Y; Fu K; Weisenburger DD; Hans CP; Campo E; Gascoyne RD; Rosenwald A; Jaffe ES; Delabie J; Rimsza L; Ott G; Müller-Hermelink HK; Connors JM; Vose JM; McKeithan T; Staudt LM; Chan WC;
    Leukemia; 2007 Nov; 21(11):2332-43. PubMed ID: 17625604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diffuse large B-cell lymphoma: therapeutic development based on clinical and biological heterogeneity].
    Miyazaki K
    Rinsho Ketsueki; 2015 Oct; 56(10):2047-55. PubMed ID: 26458444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
    Chen Y; Chen H; Fu K; Zhu XZ; Irons R
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-germinal center B-cell subtype of pediatric diffuse large B-cell lymphoma in Japan: A retrospective cohort study.
    Hori D; Kobayashi R; Nakazawa A; Iwafuchi H; Klapper W; Osumi T; Ohk K; Sekimizu M
    Pediatr Blood Cancer; 2023 May; 70(5):e30279. PubMed ID: 36860130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
    Dunleavy K; Pittaluga S; Czuczman MS; Dave SS; Wright G; Grant N; Shovlin M; Jaffe ES; Janik JE; Staudt LM; Wilson WH
    Blood; 2009 Jun; 113(24):6069-76. PubMed ID: 19380866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
    Ye ZY; Cao YB; Lin TY; Lin HL
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of diffuse large B-cell lymphoma.
    Rosenwald A; Staudt LM
    Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
    De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
    J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PROGNOSTIC ROLE OF NF-κB EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA SUBGROUPS].
    Škunca Z; Planinc-Peraica A
    Acta Med Croatica; 2015 Mar; 69(1):25-32. PubMed ID: 26606782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland.
    Reber R; Banz Y; Garamvölgyi E; Perren A; Novak U
    Swiss Med Wkly; 2013; 143():w13748. PubMed ID: 23740154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia.
    Phang KC; Akhter A; Tizen NMS; Rahman FA; Zahratul Azma R; Elyamany G; Shabani-Rad MT; Masir N; Mansoor A
    J Clin Pathol; 2018 Mar; 71(3):215-220. PubMed ID: 28775174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX; Wang JF; Wang YH; Gao N
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?
    Barton S; Hawkes EA; Wotherspoon A; Cunningham D
    Oncologist; 2012; 17(12):1562-73. PubMed ID: 23086691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
    Tagawa H; Suguro M; Tsuzuki S; Matsuo K; Karnan S; Ohshima K; Okamoto M; Morishima Y; Nakamura S; Seto M
    Blood; 2005 Sep; 106(5):1770-7. PubMed ID: 15886317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.
    Loo SK; Ch'ng ES; Md Salleh MS; Banham AH; Pedersen LM; Møller MB; Green TM; Wong KK
    Histopathology; 2017 Jul; 71(1):98-111. PubMed ID: 28248435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 95.